Open AccessNon-invasive diagnosis of cardiac amyloidosis due to transthyretin. Case report
Author(s) -
Marina Povar Echeverría,
Pablo Esteban Auquilla Clavijo,
J.A. Escobedo Palau,
P. Navarro Beltrán,
Javier Marco
Publication year - 2018
Publication title -
anales del sistema sanitario de navarra
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.175
H-Index - 23
eISSN - 2340-3527
pISSN - 1137-6627
DOI - 10.23938/assn.0295
Subject(s) - cardiac amyloidosis , medicine , transthyretin , amyloidosis , disease , scintigraphy , rare disease , intensive care medicine , radiology , pathology
Amyloidosis due to deposits of transthyretin (ATTR) is currently considered the most frequent form of cardiac amyloidosis and its incidence is increasing thanks to the advances in diagnostic imaging techniques. Some non-invasive diagnostic criteria have recently been published on this entity that due to the development of new drugs for the specific treatment of cardiac ATTR, have prognostic and therapeutic implications. That is why cardiac ATTR could cease to be a rare disease and become a frequent one, and become potentially treatable instead of incurable. We present the case of an 80-year-old male diagnosed with non-hereditary cardiac ATTR by means of gammagraphy with 99mTc diphosfonate scintigraphy (99mTc-DPD) following the new criteria of non-invasive diagnosis.